• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半合成大环脂肽抗细菌病原体的抗菌活性。

Semisynthetic Macrocyclic Lipo-lanthipeptides Display Antimicrobial Activity Against Bacterial Pathogens.

机构信息

Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen 9747 AG, The Netherlands.

出版信息

ACS Synth Biol. 2021 Aug 20;10(8):1980-1991. doi: 10.1021/acssynbio.1c00161. Epub 2021 Aug 4.

DOI:10.1021/acssynbio.1c00161
PMID:34347446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8383303/
Abstract

A large number of antimicrobial peptides depend on intramolecular disulfide bonds for their biological activity. However, the relative instability of disulfide bonds has limited the potential of some of these peptides to be developed into therapeutics. Conversely, peptides containing intramolecular (methyl)lanthionine-based bonds, lanthipeptides, are highly stable under a broader range of biological and physical conditions. Here, the class-II lanthipeptide synthetase CinM, from the cinnamycin gene cluster, was employed to create methyllanthionine stabilized analogues of disulfide-bond-containing antimicrobial peptides. The resulting analogues were subsequently modified by adding lipid tails of variable lengths through chemical addition. Finally, the created compounds were characterized by MIC tests against several relevant pathogens, killing assays, membrane permeability assays, and hemolysis assays. It was found that CinM could successfully install methyllanthionine bonds at the intended positions of the analogues and that the lipidated macrocyclic core peptides have bactericidal activity against tested Gram-positive and Gram-negative pathogenic bacteria. Additionally, fluorescence microscopy assays revealed that the lipidated compounds disrupt the bacterial membrane and lyse bacterial cells, hinting toward a potential mode of action. Notably, the semisynthesized macrocyclic lipo-lanthipeptides show low hemolytic activity. These results show that the methods developed here extend the toolbox for novel antimicrobial development and might enable the further development of novel compounds with killing activity against relevant pathogenic bacteria.

摘要

大量的抗菌肽依赖于分子内二硫键来发挥其生物活性。然而,二硫键的相对不稳定性限制了其中一些肽类发展为治疗药物的潜力。相反,含有分子内(甲基)硫醚键的肽类,即硫肽,在更广泛的生物和物理条件下具有高度的稳定性。在这里,我们采用来自肉桂霉素基因簇的 II 类硫肽合成酶 CinM,来构建含有二硫键的抗菌肽的甲基硫醚稳定类似物。然后,通过化学添加的方式,在这些类似物中添加了不同长度的脂质尾巴来对其进行进一步修饰。最后,通过 MIC 测试对几种相关病原体、杀伤实验、膜通透性实验和溶血实验对所合成的化合物进行了表征。结果发现,CinM 可以成功地在类似物的预期位置上安装甲基硫醚键,并且脂质化的大环核心肽对测试的革兰氏阳性和革兰氏阴性致病菌具有杀菌活性。此外,荧光显微镜实验表明,脂质化化合物破坏了细菌膜并裂解了细菌细胞,提示了一种潜在的作用模式。值得注意的是,半合成的大环脂硫肽显示出较低的溶血活性。这些结果表明,这里开发的方法扩展了新型抗菌药物开发的工具包,并可能使具有针对相关致病菌的杀伤活性的新型化合物的进一步开发成为可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/a8d83f601535/sb1c00161_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/f19f026c8834/sb1c00161_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/10dddf8d36ab/sb1c00161_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/ef31340026ef/sb1c00161_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/7a89d05b382b/sb1c00161_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/209d7ae03e4b/sb1c00161_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/22e672dbe82c/sb1c00161_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/ecc28f1cea51/sb1c00161_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/a8d83f601535/sb1c00161_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/f19f026c8834/sb1c00161_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/10dddf8d36ab/sb1c00161_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/ef31340026ef/sb1c00161_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/7a89d05b382b/sb1c00161_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/209d7ae03e4b/sb1c00161_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/22e672dbe82c/sb1c00161_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/ecc28f1cea51/sb1c00161_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0f/8383303/a8d83f601535/sb1c00161_0008.jpg

相似文献

1
Semisynthetic Macrocyclic Lipo-lanthipeptides Display Antimicrobial Activity Against Bacterial Pathogens.半合成大环脂肽抗细菌病原体的抗菌活性。
ACS Synth Biol. 2021 Aug 20;10(8):1980-1991. doi: 10.1021/acssynbio.1c00161. Epub 2021 Aug 4.
2
Nisin- and Ripcin-Derived Hybrid Lanthipeptides Display Selective Antimicrobial Activity against .尼生素和里普菌素衍生的杂合类杆菌肽显示出对. 的选择性抗菌活性。
ACS Synth Biol. 2021 Jul 16;10(7):1703-1714. doi: 10.1021/acssynbio.1c00080. Epub 2021 Jun 22.
3
Design, synthesis, and antimicrobial activities of novel functional peptides against Gram-positive and Gram-negative bacteria.新型功能肽的设计、合成及抗革兰氏阳性和革兰氏阴性菌活性研究。
Chem Biol Drug Des. 2019 Aug;94(2):1537-1544. doi: 10.1111/cbdd.13535. Epub 2019 Jun 2.
4
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.新型计算机设计抗菌肽对一系列细菌病原体的体外活性研究。
J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532. Epub 2013 Jul 26.
5
Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.提高基于乳链菌肽的类细菌素对革兰氏阴性病原体的抗菌活性。
Appl Environ Microbiol. 2018 May 31;84(12). doi: 10.1128/AEM.00052-18. Print 2018 Jun 15.
6
A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative Pathogens.一种便捷的化学酶法制备对革兰氏阴性病原体具有强效活性的嵌合大环肽抗生素的方法。
J Med Chem. 2021 Aug 12;64(15):10890-10899. doi: 10.1021/acs.jmedchem.1c00176. Epub 2021 Jul 20.
7
Macrocyclic Antimicrobial Peptides Engineered from ω-Conotoxin.由ω-芋螺毒素改造而来的大环抗菌肽
Curr Pharm Des. 2017;23(14):2131-2138. doi: 10.2174/1381612822666161027120518.
8
Short antimicrobial lipo-α/γ-AA hybrid peptides.短抗菌脂溶性α/γ-氨基酸杂交肽。
Chembiochem. 2014 Oct 13;15(15):2275-80. doi: 10.1002/cbic.201402264. Epub 2014 Aug 28.
9
Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.具有亲脂性烷基尾的抗菌肽陈菌素-1b的抗菌活性和自组装行为
Eur J Med Chem. 2018 Apr 25;150:546-558. doi: 10.1016/j.ejmech.2018.03.025. Epub 2018 Mar 10.
10
Total Synthesis and Biological Evaluation of the Glycosylated Macrocyclic Antibiotic Mangrolide A.糖基化大环抗生素曼格罗霉素 A 的全合成及生物评价。
Angew Chem Int Ed Engl. 2018 Aug 20;57(34):11020-11024. doi: 10.1002/anie.201805770. Epub 2018 Jul 18.

引用本文的文献

1
Promiscuity of lanthipeptide enzymes: new challenges and applications.羊毛硫肽酶的混杂性:新挑战与应用
World J Microbiol Biotechnol. 2025 Aug 6;41(8):298. doi: 10.1007/s11274-025-04505-5.
2
Biosynthesis of Antimicrobial Ornithine-Containing Lacticin 481 Analogues by Use of a Combinatorial Biosynthetic Pathway in .通过在……中使用组合生物合成途径生物合成含抗菌鸟氨酸的乳酸乳球菌素481类似物
ACS Synth Biol. 2024 Dec 20;13(12):4209-4217. doi: 10.1021/acssynbio.4c00650. Epub 2024 Dec 11.
3
Brevicidine acts as an effective sensitizer of outer membrane-impermeable conventional antibiotics for treatment.

本文引用的文献

1
BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity.短杆菌肽B,短杆菌肽家族的新成员,具有更广泛的靶点特异性。
Front Microbiol. 2021 Jun 9;12:693117. doi: 10.3389/fmicb.2021.693117. eCollection 2021.
2
Nisin- and Ripcin-Derived Hybrid Lanthipeptides Display Selective Antimicrobial Activity against .尼生素和里普菌素衍生的杂合类杆菌肽显示出对. 的选择性抗菌活性。
ACS Synth Biol. 2021 Jul 16;10(7):1703-1714. doi: 10.1021/acssynbio.1c00080. Epub 2021 Jun 22.
3
Engineering of new-to-nature ribosomally synthesized and post-translationally modified peptide natural products.
短杆菌肽可作为一种有效的增敏剂,用于增强外膜不通透性的传统抗生素的治疗效果。
Front Microbiol. 2023 Dec 15;14:1304198. doi: 10.3389/fmicb.2023.1304198. eCollection 2023.
4
Genome sequencing and analysis of VJH504 reveal biocontrol mechanism against cucumber wilt.VJH504的基因组测序与分析揭示了其对黄瓜枯萎病的生物防治机制。
Front Microbiol. 2023 Oct 12;14:1279695. doi: 10.3389/fmicb.2023.1279695. eCollection 2023.
5
A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance.当前抗生素耐药性的综述及具有新型作用模式的有前途的抗生素,以对抗抗生素耐药性。
Arch Microbiol. 2023 Oct 20;205(11):356. doi: 10.1007/s00203-023-03699-2.
6
Lipidated variants of the antimicrobial peptide nisin produced via incorporation of methionine analogs for click chemistry show improved bioactivity.通过引入甲硫氨酸类似物进行点击化学合成的抗菌肽乳酰化变体显示出改善的生物活性。
J Biol Chem. 2023 Jul;299(7):104845. doi: 10.1016/j.jbc.2023.104845. Epub 2023 May 19.
7
Striving for sustainable biosynthesis: discovery, diversification, and production of antimicrobial drugs in Escherichia coli.努力实现可持续生物合成:大肠杆菌中抗菌药物的发现、多样化和生产。
Biochem Soc Trans. 2022 Oct 31;50(5):1315-1328. doi: 10.1042/BST20220218.
8
Modular Use of the Uniquely Small Ring A of Mersacidin Generates the Smallest Ribosomally Produced Lanthipeptide.美沙西林小环 A 的模块化使用产生了最小的核糖体合成的兰尼肽。
ACS Synth Biol. 2022 Sep 16;11(9):3078-3087. doi: 10.1021/acssynbio.2c00343. Epub 2022 Sep 5.
9
Mutational Studies of the Mersacidin Leader Reveal the Function of Its Unique Two-Step Leader Processing Mechanism.突变研究揭示了 Mersacidin 前导序列的独特两步前导序列加工机制的功能。
ACS Synth Biol. 2022 May 20;11(5):1949-1957. doi: 10.1021/acssynbio.2c00088. Epub 2022 May 3.
新型核糖体合成及翻译后修饰肽类天然产物的工程化
Curr Opin Biotechnol. 2021 Jun;69:221-231. doi: 10.1016/j.copbio.2020.12.022. Epub 2021 Feb 5.
4
Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs).核糖体合成和翻译后修饰肽(RiPPs)的抗病毒活性及应用。
Cell Mol Life Sci. 2021 Apr;78(8):3921-3940. doi: 10.1007/s00018-021-03759-0. Epub 2021 Feb 2.
5
Combinatorial biosynthesis for the generation of new-to-nature peptide antimicrobials.组合生物合成生成新型天然肽类抗生素。
Biochem Soc Trans. 2021 Feb 26;49(1):203-215. doi: 10.1042/BST20200425.
6
New developments in RiPP discovery, enzymology and engineering.RiPP 发现、酶学和工程的新进展。
Nat Prod Rep. 2021 Jan 1;38(1):130-239. doi: 10.1039/d0np00027b. Epub 2020 Sep 16.
7
Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification.核糖体合成和翻译后修饰模拟非核糖体产生的抗菌肽 Brevicidine。
Cell Chem Biol. 2020 Oct 15;27(10):1262-1271.e4. doi: 10.1016/j.chembiol.2020.07.005. Epub 2020 Jul 23.
8
Characterization of two relacidines belonging to a novel class of circular lipopeptides that act against Gram-negative bacterial pathogens.鉴定两种新型环状脂肽类赖氨酰菌素,它们对革兰氏阴性细菌病原体有抑制作用。
Environ Microbiol. 2020 Dec;22(12):5125-5136. doi: 10.1111/1462-2920.15145. Epub 2020 Jul 20.
9
High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB.高通量筛选尼生素脱水酶 NisB 的底物特异性适应性突变体。
ACS Synth Biol. 2020 Jun 19;9(6):1468-1478. doi: 10.1021/acssynbio.0c00130. Epub 2020 May 22.
10
Substrate Recognition by the Class II Lanthipeptide Synthetase HalM2.II类羊毛硫肽合成酶HalM2对底物的识别
ACS Chem Biol. 2020 Jun 19;15(6):1473-1486. doi: 10.1021/acschembio.0c00127. Epub 2020 Apr 28.